Geneohm Sciences Canada, Inc.

Geneohm Sciences, Inc.

UniversitÈ Laval

Genohm Sciences Canada, Inc.

Becton Dickinson Infusion Therapy Systems Inc.

Ann Huletsky

Michel G Bergeron

Marc Ouellette

Maurice Boissinot

Paul H Roy

Valery Rossbach

Francois J Picard

François J Picard

Christian Menard

Christian Ménard

Richard Giroux

Régis Peytavi

Lucile Belley-Montfort

Isabelle Martineau

Christian M Nard

Described herein are novel SCCmec right extremity junction (MREJ) sequences for the detection and/or identification of methicillin-resistant(MRSA). Disclosed are methods and compositions based on DNA sequences for the specific detection of MREJ sequences designated types xi, xii, xiii, xiv, xv, xvi, xvii, xviii, xix, and xx for diagnostic purposes and/or epidemiological typing.

Sequences for detection and identification of methicillin-resistant(MRSA) of MREJ types xi to xx

The present invention describes novel SCCmec right extremity junction sequences for the detection of methicillin-resistant(MRSA). It relates to the use of these DNA sequences for diagnostic purposes.

Method for the detection and identification of methicillin-resistant

Provided herein are compositions and methods for the detection of

[object Object]

The present invention relates to a method for isolating microorganisms and/or microorganisms nucleic acids from a bodily fluid that may comprise or may be suspected to comprise microorganisms and/or host cells and/or host cells debris. Microorganisms nucleic acids may further be isolated by lysing the isolated microorganisms. The present invention also relates to a method for detecting microorganisms in a bodily fluid. The present invention further relates to a saponin formulation and its use.

Concentration and enrichment of microbial cells and microbial nucleic acids from bodily fluids

Compositions and methods for the detection of vancomycin-resistant pathogens using primers and/or probes to the vanA and vanB genes.

Methods and probes for detecting a vancomycin resistance gene

Four highly conserved genes, encoding translation elongation factor Tu, translation elongation factor G, the catalytic subunit of proton-translocating ATPase and the RecA recombinase, are used to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical pathogens from clinical specimens for diagnosis. The detection of associated antimicrobial agents resistance and toxin genes are also under the scope of the present invention.

Highly conserved genes and their use to generate probes and primers for detection of microorganisms

Growing community of inventors

Sillery, Canada

Ann Huletsky